Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need

J Clin Psychiatry. 2009 May;70(5):765-6. doi: 10.4088/jcp.09ac05255.
No abstract available

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Aripiprazole
  • Benzodiazepines / adverse effects*
  • Clozapine / adverse effects*
  • Diabetes Mellitus / chemically induced*
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology
  • Diabetic Ketoacidosis / chemically induced*
  • Diabetic Ketoacidosis / diagnosis
  • Diabetic Ketoacidosis / epidemiology
  • Dibenzothiazepines / adverse effects*
  • Humans
  • Mass Screening*
  • Olanzapine
  • Piperazines / adverse effects*
  • Predictive Value of Tests
  • Prospective Studies
  • Quetiapine Fumarate
  • Quinolones / adverse effects*
  • Severity of Illness Index

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Piperazines
  • Quinolones
  • Benzodiazepines
  • Quetiapine Fumarate
  • Aripiprazole
  • Clozapine
  • Olanzapine